Trials / Terminated
TerminatedNCT03613493
Acceptability of Human Papillomavirus (HPV) Self-sampling Tools for Cervical Cancer Prevention
Acceptability of HPV Self-sampling Tools for Cervical Cancer Prevention in Jamaican Women: A Theory-based Approach to Culturally-tailored Message Design
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 175 (actual)
- Sponsor
- University of Miami · Academic / Other
- Sex
- Female
- Age
- 30 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
The proposed study aims to increase HPV screening behaviors in Jamaican women by examining the acceptability of HPV Deoxyribonucleic Acid (DNA) self-sampling tools, and to determine the most culturally appropriate and effective message design for promoting such a tool in this context.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | HPV self-sampling kit | The HPV self-sampler kit will include the collection swab and the vial for collecting and storing the specimen, and an instructional sheet that visually depicts the steps for self-sampling. |
| BEHAVIORAL | Culturally-targeted Fear Appeal Message | Participants will receive culturally-targeted and fear appeal messages in a graphically designed kit. |
| BEHAVIORAL | Fear Appeal Message | Participants will receive fear appeal messages (only) in a graphically designed kit. |
| BEHAVIORAL | Interview | Participants will be interviewed about experiences using the self-sampling tool (qualitative). |
Timeline
- Start date
- 2018-07-10
- Primary completion
- 2018-10-01
- Completion
- 2018-10-01
- First posted
- 2018-08-03
- Last updated
- 2019-08-02
- Results posted
- 2019-08-02
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT03613493. Inclusion in this directory is not an endorsement.